Senard JM - Search Results

1

Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease.

Courbon F, Brefel-Courbon C, Thalamas C, Alibelli MJ, Berry I, Montastruc JL, Rascol O, Senard JM. Courbon F, et al. Among authors: senard jm. Mov Disord. 2003 Aug;18(8):890-7. doi: 10.1002/mds.10461. Mov Disord. 2003. PMID: 12889078

2

Clinical and economic analysis of spa therapy in Parkinson's disease.

Brefel-Courbon C, Desboeuf K, Thalamas C, Galitzky M, Senard JM, Rascol O, Montastruc JL. Brefel-Courbon C, et al. Among authors: senard jm. Mov Disord. 2003 May;18(5):578-84. doi: 10.1002/mds.10404. Mov Disord. 2003. PMID: 12722173 Clinical Trial.

3

Heat-related morbidity in patients with orthostatic hypotension and primary autonomic failure.

Pathak A, Lapeyre-Mestre M, Montastruc JL, Senard JM. Pathak A, et al. Among authors: senard jm. Mov Disord. 2005 Sep;20(9):1213-9. doi: 10.1002/mds.20571. Mov Disord. 2005. PMID: 15954131

4

Cerebral autoregulation is preserved in multiple system atrophy: A transcranial Doppler study.

Pavy-Le Traon A, Hughson RL, Thalamas C, Galitsky M, Fabre N, Rascol O, Senard JM. Pavy-Le Traon A, et al. Among authors: senard jm. Mov Disord. 2006 Dec;21(12):2122-6. doi: 10.1002/mds.21130. Mov Disord. 2006. PMID: 17029266

5

Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease.

Rascol O, Sabatini U, Fabre N, Senard JM, Simonetta-Moreau M, Montastruc JL, Clanet M, Rascol A. Rascol O, et al. Among authors: senard jm. Mov Disord. 1995 Mar;10(2):163-70. doi: 10.1002/mds.870100206. Mov Disord. 1995. PMID: 7753058

6

Lacrimation in Parkinson's disease.

Bagheri H, Berlan M, Senard JM, Rascol O, Montastruc JL. Bagheri H, et al. Among authors: senard jm. Clin Neuropharmacol. 1994 Feb;17(1):89-91. Clin Neuropharmacol. 1994. PMID: 8149363

7

Treatment of Parkinson's disease should begin with a dopamine agonist.

Montastruc JL, Rascol O, Senard JM. Montastruc JL, et al. Among authors: senard jm. Mov Disord. 1999 Sep;14(5):725-30. doi: 10.1002/1531-8257(199909)14:5<725::aid-mds1003>3.0.co;2-l. Mov Disord. 1999. PMID: 10495032 Review.

8

Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease.

Montastruc JL, Desboeuf K, Lapeyre-Mestre M, Senard JM, Rascol O, Brefel-Courbon C. Montastruc JL, et al. Among authors: senard jm. Mov Disord. 2001 May;16(3):511-4. doi: 10.1002/mds.1093. Mov Disord. 2001. PMID: 11391747 Clinical Trial.

9

Combined cardiovascular and sweating autonomic testing to differentiate multiple system atrophy from Parkinson's disease.

Pavy-LeTraon A, Brefel-Courbon C, Dupouy J, Ory-Magne F, Rascol O, Senard JM. Pavy-LeTraon A, et al. Among authors: senard jm. Neurophysiol Clin. 2018 Apr;48(2):103-110. doi: 10.1016/j.neucli.2017.11.003. Epub 2017 Dec 14. Neurophysiol Clin. 2018. PMID: 29249575

10

Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease.

Rascol O, Fabre N, Blin O, Poulik J, Sabatini U, Senard JM, Ané M, Montastruc JL, Rascol A. Rascol O, et al. Among authors: senard jm. Mov Disord. 1994 Jul;9(4):437-40. doi: 10.1002/mds.870090410. Mov Disord. 1994. PMID: 7969211 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

245 results

Search Page